This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Isis Pharmaceuticals, Inc., Verastem, Inc.. Active years: 2005-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2016
Title: Yali Jennifer Tsai: Innovator in Bioactive Compound Formulations
Introduction
Yali Jennifer Tsai is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of bioactive compounds, particularly in the development of formulations that enhance the delivery and efficacy of various therapeutic agents. With a total of 3 patents, her work is pivotal in advancing medical treatments.
Latest Patents
One of her latest patents focuses on oral formulations of kinase inhibitors. This invention is directed to formulations of bioactive compounds with limited water solubility, specifically inhibitors of focal adhesion kinase (FAK) of the 2,4-diaminopyridine class. These formulations are designed for oral administration, providing enhanced absorption and bioavailability of the compounds as dispersions or emulsions in an oil base. For instance, esters of PEG-ylated glycerol can be utilized as the oil, along with surfactants such as lecithin and TEPG succinate, and solubilizers like PEG 400. This innovation is particularly beneficial for patients with conditions where FAK inhibition is medically indicated, such as cancer or arthritis.
Another significant patent by Tsai involves compositions and methods for the topical delivery of oligonucleotides. This invention enhances the delivery of oligonucleotides and other nucleosidic moieties through topical administration routes. The preferred compositions include liposomes or penetration enhancers that facilitate the delivery of these moieties to dermal and/or epidermal tissue in animals for investigative, therapeutic, or prophylactic purposes.
Career Highlights
Throughout her career, Yali Jennifer Tsai has worked with notable companies, including Isis Pharmaceuticals, Inc. and Verastem, Inc. Her experience in these organizations has contributed to her expertise in the field of bioactive compounds and their applications in medicine.
Collaborations
Yali has collaborated with esteemed colleagues such as Rahul C. Mehta and Gregory E. Hardee. These collaborations have further enriched her research and development efforts in the field.
Conclusion
Yali Jennifer Tsai is a distinguished inventor whose work in bioactive compound formulations has the potential to significantly impact medical treatments. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile